1.Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial.By Meg Tirrell, CNN.Published July 30, 2024 2.Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial.July 30,...
2.Amgen shares soar as executives outline obesity drug push;BioPharma Dive 3.Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound;BioPharma Dive’s 4.Chinese pharma to ride on the global GLP-1 drugs bonanza;Nom...
这或许，同样适用于GLP-1。因为GLP-1治疗阿尔兹海默症，也是基于一个尚未被证实的机制——炎症假说。今年9月，发表在nauter上的一篇论文，《Why do obesity drugs seem to treat so many other ailments?》，探讨了GLP-1类药物的多种可能益处，以及科学家们对其背后机制的研究进展。其中，就包括炎症假说。一项针对...
参考资料 GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
参考文献 DRUCKER D J. The benefits of GLP-1 drugs beyond obesity[J]. Science, 2024, 385(6706): 258-260. DOI: 10.1126/science.adn4128.“医学论坛网”发布医学领域研究成果和解读，供专业人员科研参考，不作为诊疗标准，使用需根据具体情况评估。编辑：连翘 二审：清扬 三审：碧泉 排版：半夏 ...
1.Livingston, S. Weight-loss drugs will remain out of reach for millions in 2024 as employers and insurance companies reduce coverage. Business Insider. 30. 12. 2023.2.Treasurer Folwell Calls on Novo Nordisk to Lower the Unfair Cost of Weight Loss Drugs. North Carolina Department of State ...
希望司美格鲁肽类药物在未来,能够拥有一个更美好的结局。 参考资料 1.The Year of Ozempic.New Yorker. 2.Her work paved the way for blockbuster obesity drugs. Now, she’s fighting for recognition.Science. ! 请注明:姓名+研究方向! 版 权 声 明...
1.Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial.By Meg Tirrell, CNN.Published July 30, 2024 2.Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial.July 30, 2024.Nick Paul Taylor ...
[9] Lee, E.S., Youn, Y.S. Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. Journal of Pharmaceutical Investigation 46, 305–315 (2016). [10] 猎药人俱乐部:GLP-1RA长效策略:联合融合蛋白/抗体技术,续写“延长GLP-1半衰期”的新篇章 ...
Chinese pharma to ride on the global GLP-1 drugs bonanza;Nomura Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China;Fierce Pharma 中国GLP-1类“减肥”新药3期临床试验一览;医药观澜